The result showed the infarction volume was significantly smaller in CD34+ pre-treatment group (84.94 ± 37.14 mm3) than no treatment group (177.22 ± 28.39 mm3, p = 0.011) on T2-weighted images obtained at 2 d after MCAO (Fig 1). This evidence concerns the gene CD34 and infarction.